Gastroesophageal Reflux Symptoms not Responding to Proton Pump Inhibitor: GERD, NERD, NARD, Esophageal Hypersensitivity or Dyspepsia?
作者： Mohammad Bashashati , Reza A Hejazi , Christopher N Andrews , Martin A Storr
DOI: 10.1155/2014/904707
关键词:
摘要: … and duodenal contents into the esophagus may also induce GER … Esophageal hypersensitivity or functional dyspepsia with … the pathophysiology of esophageal hypersensitivity are not …
core.ac.uk
hindawi.com参考文章(83)
Michael F. Vaezi, Use of symptom indices in the management of GERD. Gastroenterología y Hepatología. ,vol. 8, pp. 185- 187 ,(2012)
Martin A Storr, What Is Nonacid Reflux Disease Canadian Journal of Gastroenterology & Hepatology. ,vol. 25, pp. 35- 38 ,(2011) , 10.1155/2011/626752
Lionel M. Bernstein, Lyle A. Baker, A clinical test for esophagitis. Gastroenterology. ,vol. 34, pp. 760- 781 ,(1958) , 10.1016/S0016-5085(58)80023-2
Tiberiu Hershcovici, Sami R Achem, LK Jha, Ronnie Fass, None, Systematic review: the treatment of noncardiac chest pain Alimentary Pharmacology & Therapeutics. ,vol. 35, pp. 5- 14 ,(2012) , 10.1111/J.1365-2036.2011.04904.X
Ronnie Fass, Therapeutic options for refractory gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 3- 7 ,(2012) , 10.1111/J.1440-1746.2012.07064.X
Yukie Kohata, Yasuhiro Fujiwara, Hirohisa Machida, Hirotoshi Okazaki, Hirokazu Yamagami, Tetsuya Tanigawa, Kenji Watanabe, Toshio Watanabe, Kazunari Tominaga, Tetsuo Arakawa, Pathogenesis of proton‐pump inhibitor‐refractory non‐erosive reflux disease according to multichannel intraluminal impedance‐pH monitoring Journal of Gastroenterology and Hepatology. ,vol. 27, pp. 58- 62 ,(2012) , 10.1111/J.1440-1746.2012.07074.X
Takahisa Furuta, Mitsushige Sugimoto, Naohito Shirai, Individualized Therapy for Gastroesophageal Reflux Disease Molecular Diagnosis & Therapy. ,vol. 16, pp. 223- 234 ,(2012) , 10.1007/BF03262211
M. P. L. Guarino, L. Cheng, J. Ma, K. Harnett, P. Biancani, A. Altomare, F. Panzera, J. Behar, M. Cicala, Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterology and Motility. ,vol. 22, pp. 746- ,(2010) , 10.1111/J.1365-2982.2010.01514.X
A. L. Krarup, L. Ny, M. Åstrand, A. Bajor, F. Hvid-Jensen, M. B. Hansen, M. Simrén, P. Funch-Jensen, A. M. Drewes, Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Alimentary Pharmacology & Therapeutics. ,vol. 33, pp. 1113- 1122 ,(2011) , 10.1111/J.1365-2036.2011.04629.X
Nicholas E. Diamant, Pathophysiology of gastroesophageal reflux disease GI Motility online. ,(2006) , 10.1038/GIMO21